NFKB1 and hydrops fetalis: Whereas infliximab did effectively reverse the IB-MECA-induced increments in RVLM-NFκB expression and decrements in total HRV markers (SDNN and total power) and cardiac vagal activity (rMSSD), it failed to alter the associated falls in blood pressure and cardiac sympathovagal balance (LF/HF ratio).